Stock IRMD IRADIMED CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus IRADIMED CORPORATION

Equities

IRMD

US46266A1097

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-03 pm EDT 		5-day change 1st Jan Change
44.7 USD +1.94% Intraday chart for IRADIMED CORPORATION +6.78% -5.84%
May. 02 Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024
May. 02 Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M MT

Evolution of the average Target Price on IRADIMED CORPORATION

Price target over the last 5 years

History of analyst recommendation changes

74a4be082e3ecb6c1868e6b1c36.egbv-BtX-1BE158zMeeUjSIYpUHO62Xvka7FJBz8S5g.Vz-fv0Mvsxd2sexAbp39ynVS0wzjsTSl-pz0fn2QJfoJVaKQdzGdNzaj8A~52743e7f0a8e41d9f402cc29193c7297

Analyst Recommendations on IRADIMED CORPORATION

Roth Capital Adjusts IRadimed's Price Target to $42 From $36, Maintains Buy Rating MT
IRADIMED : Roth Capital Adjusts iRadimed's Price Target to $36 from $32, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
44.7 USD
Average target price
62.5 USD
Spread / Average Target
+39.82%
High Price Target
65 USD
Spread / Highest target
+45.41%
Low Price Target
60 USD
Spread / Lowest Target
+34.23%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IRADIMED CORPORATION

Roth Capital Partners

Ratings for IRADIMED CORPORATION

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION